Tourmaline Bio, Inc. (TRML)
NASDAQ: TRML · Real-Time Price · USD
16.65
-0.08 (-0.48%)
At close: Mar 28, 2025, 4:00 PM
16.62
-0.03 (-0.19%)
After-hours: Mar 28, 2025, 7:57 PM EDT
Tourmaline Bio Market Cap
Tourmaline Bio has a market cap or net worth of $427.66 million as of March 28, 2025. Its market cap has decreased by -63.26% in one year.
Market Cap
427.66M
Enterprise Value
169.60M
1-Year Change
-63.26%
Ranking
Category
Stock Price
$16.65
Market Cap Chart
Since October 20, 2023, Tourmaline Bio's market cap has increased from $221.67M to $427.66M, an increase of 92.93%. That is a compound annual growth rate of 57.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 427.66M | -17.76% |
| Dec 31, 2024 | 520.03M | -2.33% |
| Dec 29, 2023 | 532.42M | 140.18% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |